Skip to main content

2 Result(s)

within Mari Tanaka-Kubota Remove this filter

and

  1. No Access

    Article

    Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases

    The purpose of our study was to compare the safety and efficacy of hematopoietic cell transplantation (HCT) using fludarabine (Flu)-based reduced intensity conditioning (RIC) with busulfan (BU) or melphalan (M...

    Akira Nishimura, Yuki Aoki, Yasuyoshi Ishiwata… in Journal of Clinical Immunology (2021)

  2. No Access

    Article

    Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease

    Pulmonary alveolar proteinosis (PAP) is a rare disorder that is characterized by the excessive accumulation of surfactant-like materials in the alveoli, leading to hypoxemic respiratory failure. We describe tw...

    Mari Tanaka-Kubota, Koji Shinozaki, Satoshi Miyamoto… in International Journal of Hematology (2018)